Eupraxia Pharmaceuticals (OTCMKTS:EPRXF – Get Free Report) and Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Analyst Ratings This is a breakdown of current […]
Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) was the target of a large increase in short interest during the month of June. As of June 30th, there was short interest totalling 2,600 shares, an increase of 420.0% from the June 15th total of 500 shares. Based on an average daily trading volume, of 100 […]
Short Interest in Eupraxia Pharmaceuticals Inc (OTCMKTS:EPRXF) Rises By 420 0% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF – Free Report) had its price objective raised by Raymond James from C$11.00 to C$17.00 in a research report sent to investors on Tuesday morning, The Fly reports. Eupraxia Pharmaceuticals Stock Performance Shares of OTCMKTS:EPRXF opened at C$6.29 on Tuesday. Eupraxia Pharmaceuticals has a one year low of C$2.66 and a one […]
Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Rating) was the recipient of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 500 shares, a decline of 16.7% from the May 15th total of 600 shares. Based on an average daily trading volume, of 2,800 shares, […]